(Q35803978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

O M Takayanagui

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P S Bonato

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S A C Dreossi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Clinical Pharmacology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

125-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes

12 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

The penetration of anti-infectives into the central nervous system

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Pharmacokinetic optimisation of the treatment of neurocysticercosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Increased systemic availability of albendazole when taken with a fatty meal

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Clinical pharmacokinetics of albendazole in patients with brain cysticercosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874411

Pharmacokinetics of albendazole in man

25 September 2018

1 reference

12 December 2020

Albendazole sulfonation by rat liver cytochrome P-450c

1 reference

12 December 2020

Albendazole kinetics in patients with echinococcosis: delayed absorption and impaired elimination in cholestasis

1 reference

12 December 2020

Dexamethasone increases plasma levels of albendazole

1 reference

12 December 2020

Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats

1 reference

12 December 2020

Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes

1 reference

12 December 2020

Therapy for Neurocysticercosis

1 reference

12 December 2020

Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma

1 reference

12 December 2020

Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis

1 reference

12 December 2020

10.1046/J.1365-2125.2002.01634.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12207631%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference